SCHEMBL28707102

SCHEMBL28707102

CSc1cc(O)ccc1NC(=O)OC(C)(C)C

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MIF P14174 1/20 0.40
▸ RXFP1 Q9HBX9 1/20 0.40
▸ NQO2 P16083 1/20 0.39
▸ POLB P06746 2/20 0.39
▸ CYP17A1 P05093 1/20 0.38
▸ ALDH1A1 P00352 1/20 0.37
▸ MAPT P10636 1/20 0.37
▸ L3MBTL1 Q9Y468 1/20 0.37
▸ LMNA P02545 1/20 0.37
▸ KCNQ4 P56696 1/20 0.37
▸ KCNQ5 Q9NR82 1/20 0.37
▸ CCR2 P41597 1/20 0.37
▸ MEN1 O00255 2/20 0.36
▸ KMT2A Q03164 2/20 0.36
▸ ATR Q13535 1/20 0.36
▸ BRD9 Q9H8M2 1/20 0.36
▸ NPC1 O15118 1/20 0.36
▸ GAA P10253 1/20 0.36
▸ RAB9A P51151 1/20 0.36
▸ PDK1 Q15118 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28705000 0.85 NQO2 (0.39) MIFRXFP1NQO2POLBCYP17A1
SCHEMBL29618957 0.83 HPGD (0.47) MIFRXFP1NQO2POLBCYP17A1
SCHEMBL24362149 0.83 HPGD (0.47) MIFRXFP1NQO2POLBCYP17A1
SCHEMBL19519029 0.81 KMT2A (0.53) RXFP1POLBALDH1A1MAPTL3MBTL1
SCHEMBL2770751 0.80 SMN1; SMN2 (0.47) MIFRXFP1NQO2POLBALDH1A1
SCHEMBL29958958 0.80 SMN1; SMN2 (0.47) MIFRXFP1NQO2POLBALDH1A1
SCHEMBL2363945 0.79 CYP17A1 (0.53) MIFRXFP1NQO2POLBCYP17A1
SCHEMBL31619048 0.79 KMT2A (0.52) MIFRXFP1ALDH1A1MAPTLMNA
SCHEMBL1767849 0.79 KMT2A (0.52) MIFRXFP1ALDH1A1MAPTLMNA
SCHEMBL29834708 0.79 CYP17A1 (0.53) MIFRXFP1NQO2POLBCYP17A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3999057-A1 POLYAROMATIC UREA DERIVATIVES AND THEIR USE IN THE TREATMENT OF MUSCLE DISEASES ANAGENESIS BIOTECHNOLOGIES SAS (FR) 2022-05-25 — — EP disclosed
CN-114144410-A Polyarylurea derivatives and their use in the treatment of muscular diseases 阿纳格纳斯生物技术股份有限公司 2022-03-04 — — CN disclosed
Send feedback